LIMITED STAGE SMALL-CELL LUNG CANCER
Clinical trials for LIMITED STAGE SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LIMITED STAGE SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LIMITED STAGE SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop lung cancer relapse after Chemo-Radiation
Disease control OngoingThis phase 3 study tests whether tarlatamab, an experimental drug, can delay cancer progression or improve survival in people with limited-stage small-cell lung cancer who have finished chemoradiation without their cancer getting worse. About 404 participants will receive either …
Matched conditions: LIMITED STAGE SMALL-CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New immunotherapy combo shows promise for tough lung cancer
Disease control OngoingThis phase 3 trial is testing whether adding the immunotherapy drug serplulimab to standard chemoradiotherapy helps people with limited-stage small cell lung cancer live longer and keep the cancer from growing. About 511 participants will receive either serplulimab or a placebo a…
Matched conditions: LIMITED STAGE SMALL-CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC